Genmin Quote - GEN

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.033

Bid

0.033

Offer

0.034

Volume

140,000

0.033 Day's Range 0.033

0.032 52 Week Range 0.1725

Market Cap

22.613M

Previous Close

0.0325

Open

0.033

Last Trade

140000

0.033

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

786,860

Shares Outstanding

685,229,436

Dividend Yield

PE Ratio

-1.56

Earnings Per Share (EPS)

-0.02

Revenue

32k

Net Profit

-13.18M

Sector

Metal Mining Services

Industry

Metal Mining Services

Website

genmingroup.com

Headquarters

Perth, Western Australia, Aus

Founded

Genmin Limited is listed in the Metal Mining Services sector of the Australian Stock Exchange with ticker GEN. The last closing price for Genmin was AUD0.03. Over the last year, Genmin shares have traded in a share price range of AUD 0.032 to AUD 0.1725.

Genmin currently has 685,229,436 shares in issue. The market capitalisation of Genmin is AUD22.27 million. Genmin has a price to earnings ratio (PE ratio) of -1.56.

Genmab Files IND for HuMax-TF-ADC

Company Announcement IND for HuMax(R)-TF-ADC submitted to FDA Genmab's first IND submission for antibody-drug conjugate (ADC) product Patient enrolment in clinical trial expected...

Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec refused re-hearing in Arzerra patent infringement case COPENHAGEN, Denmark, July 15, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN...

Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder

Company Announcement First Phase III study with subcutaneous formulation of ofatumumab Ofatumumab to be investigated in new autoimmune area - pemphigus vulgaris Patient...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhe

Media Release Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax(R)-TAC with next generation PBD-based warhead technology 50:50 partnership ...

Teprotumumab Restarts Clinical Development in New Indication

Company Announcement Teprotumumab (RG1507) to be investigated for new indication River Vision Development Corporation to conduct clinical development under a license from Roche...

Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Company Announcement Genmab establishes Sponsored Level 1 ADR program Genmab ADRs can be traded on US over-the-counter (OTC) market effective today ADR ticker symbol GMXAY...

GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in P

Company Announcement Median 22.4 month progression free survival in patients treated with ofatumumab plus chlorambucil, an improvement of 9.3 months compared to chlorambucil alone No...

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced...

Genmab Announces Financial Results for the First Quarter of 2013

COPENHAGEN, Denmark, May 7, 2013 (GLOBE NEWSWIRE) -- Interim Report First Quarter 2013 Arzerra(r) received approval in Japan Arzerra net sales increased 65% over Q1...

Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocy

Company Announcement 95% overall response rate and 43% complete response rate in patients with previously untreated chronic lymphocytic leukemia 74% overall response rate and 11...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.001	-2.94117647059	0.034	0.036	0.033	441258	0.03403332	DE
4	-0.008	-19.512195122	0.041	0.043	0.032	688976	0.03653218	DE
12	-0.0165	-33.3333333333	0.0495	0.05	0.032	786860	0.04132442	DE
26	-0.087	-72.5	0.12	0.15	0.032	631668	0.05338786	DE
52	-0.067	-67	0.1	0.1725	0.032	748858	0.0804026	DE
156	-0.222	-87.0588235294	0.255	0.28	0.032	377728	0.11263238	DE
260	-0.287	-89.6875	0.32	0.34	0.032	397243	0.15684448	DE

GEN - Frequently Asked Questions (FAQ)

What is the current Genmin share price?

The current share price of Genmin is AUD 0.033

How many Genmin shares are in issue?

Genmin has 685,229,436 shares in issue

What is the market cap of Genmin?

The market capitalisation of Genmin is AUD 22.27M

What is the 1 year trading range for Genmin share price?

Genmin has traded in the range of AUD 0.032 to AUD 0.1725 during the past year

What is the PE ratio of Genmin?

The price to earnings ratio of Genmin is -1.56

What is the reporting currency for Genmin?

Genmin reports financial results in AUD

What is the latest annual turnover for Genmin?

The latest annual turnover of Genmin is AUD 32k

What is the latest annual profit for Genmin?

The latest annual profit of Genmin is AUD -13.18M

What is the registered address of Genmin?

The registered address for Genmin is LONDON HOUSE, SUITE 3 LEVEL 8, 216 ST GEORGES TERRACE, PERTH, WESTERN AUSTRALIA, 6000

What is the Genmin website address?

The website address for Genmin is genmingroup.com

Which industry sector does Genmin operate in?

Genmin operates in the METAL MINING SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FXGOFelix Gold Ltd	AUD 0.021 (250.00%)	100k
CRIOCritica Ltd	AUD 0.002 (100.00%)	1M
EDEEden Innovations Ltd	AUD 0.0015 (50.00%)	6.03M
AAUAntilles Gold Limited	AUD 0.005 (42.86%)	6.16M
1TTThrive Tribe Technologies Ltd	AUD 0.0035 (40.00%)	40.43M
REMORemSense Technologies Ltd	AUD 0.001 (-50.00%)	180k
NC6OBNanollose Limited	AUD 0.005 (-44.44%)	731.11k
NUZOANeurizon Therapeutics Ltd	AUD 0.054 (-34.15%)	1.18M
EXTODExcite Technology Services Ltd	AUD 0.002 (-33.33%)	1.8M
GMNGold Mountain Limited	AUD 0.002 (-33.33%)	1.31M
SYASayona Mining Limited	AUD 0.0235 (0.00%)	53.54M
1TTThrive Tribe Technologies Ltd	AUD 0.0035 (40.00%)	40.43M
SGRStar Entertainment Group Limited	AUD 0.14 (3.70%)	38.93M
GCMGreen Critical Minerals Ltd	AUD 0.021 (5.00%)	38.33M
CNDCondor Energy Ltd	AUD 0.032 (14.29%)	31.87M